|
|||||
|
|
Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials |
|
| Authors: | Thomas F. Dejgaard PhD Bernt J. von Scholten DMSc Erik Christiansen DMSc Frederik F. Kreiner PhD Lars Bardtrum MSc Matthias von Herrath MD Chantal Mathieu MD Sten Madsbad DMSc ADJUNCT ONE ADJUNCT TWO Investigators |
| Affiliation: | 1. Steno Diabetes Center Copenhagen, Gentofte, Denmark;2. Novo Nordisk A/S, Søborg, Denmark;3. University of Leuven, Leuven, Belgium;4. Hvidovre University Hospital, University of Copenhagen, Hvidovre, Denmark |
| Abstract: | |
| Keywords: | clinical trial incretin therapy liraglutide type 1 diabetes |